论文部分内容阅读
HyalPharmaceuticals公司的Hyal－CT－1101凝胶（二氯芬酸／透明质酸，商品名Solarase）已获得英国药品安全委员会的上市许可，用于治疗光化性角化病（雀斑）。Hyal-CT－1101的批准是以完成某些管理手续而定的，并且本品在英国的上市是以达成授让协议为依据的。皿期临床研究中
Hyal-CT-1101 gel from Hyal Pharmaceuticals (Diclofenac / Hyaluronic Acid, trade name Solarase) has been licensed by the British Medicines and Safety Board for the treatment of actinic keratosis (freckles). The approval of Hyal-CT-1101 is subject to the completion of certain regulatory formalities, and the listing of the product in the United Kingdom is based on the grant of an agreement. Pancreatic phase clinical research